Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Sarcopenia | Research

Sex differences in the association between sarcopenia and mild cognitive impairment in the older Korean population

Authors: Hyo-jung Lee, Ju-Young Choi, Dongui Hong, Donghoon Kim, Jin-Young Min, Kyoung-Bok Min

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Background

A link between sarcopenia and cognitive function has been proposed and is supported by several investigations. Nevertheless, the sex-linked relationship between these two diseases has been scarcely investigated. This cross-sectional study investigated sex differences in the association between sarcopenia and mild cognitive impairment.

Methods

We included all 286 participants aged 60 years or older with MCI who visited the Department of Neurology at Veterans Health Service Medical Center in South Korea from January to December 2021. The diagnosis of MCI was confirmed by two neurologists based on the participants’ neuropsychological test scores. Diagnosis of sarcopenia was based on the algorithm of Asian Working Group for Sarcopenia (AWGS) 2019 including bioelectrical impedance analysis and handgrip strength, and cognitive function was assessed using Seoul Neuropsychological Screening Battery Core (SNSB-C) test.

Results

Among the 286 participants, 171 and 112 were men and women. After adjustment for potential covariates including APOE genotype, in women participants, there were significant associations between diagnosis of sarcopenia and MCI (OR = 4.72, 95%CI [1.39–15.97]), while there was no significant relationship in men participants. In eight subdomains of SNSB-C, we also found that women participants with sarcopenia demonstrated a significant memory decline (OR = 3.21, 95%CI [1.01–10.19]) as compared with the reference women group without sarcopenia after adjusting all covariates mentioned above. No significant association between any SNSB-C subdomain and MCI was demonstrated in men participants.

Conclusions

We demonstrated that there was a different relationship between sarcopenia and MCI by sex and that sarcopenia may affect the cognitive subdomain differently by sex. These results imply that, with regard to cognitive function, maintaining muscle function and muscle mass might be more crucial for women than for men.
Literature
1.
go back to reference Chen L-K, Woo J, Assantachai P, Auyeung T-W, Chou M-Y, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300-7.e2.PubMedCrossRef Chen L-K, Woo J, Assantachai P, Auyeung T-W, Chou M-Y, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300-7.e2.PubMedCrossRef
2.
go back to reference Mayhew AJ, Amog K, Phillips S, Parise G, McNicholas PD, de Souza RJ, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2018;48(1):48–56.CrossRef Mayhew AJ, Amog K, Phillips S, Parise G, McNicholas PD, de Souza RJ, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2018;48(1):48–56.CrossRef
3.
go back to reference Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord. 2017;16(1):21.PubMedPubMedCentralCrossRef Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord. 2017;16(1):21.PubMedPubMedCentralCrossRef
5.
go back to reference Maggio M, Lauretani F, Ceda GP. Sex hormones and sarcopenia in older persons. Curr Opin Clin Nutr Metab Care. 2013;16(1):3–13.PubMed Maggio M, Lauretani F, Ceda GP. Sex hormones and sarcopenia in older persons. Curr Opin Clin Nutr Metab Care. 2013;16(1):3–13.PubMed
6.
go back to reference Kim YJ, Tamadon A, Park HT, Kim H, Ku S-Y. The role of sex steroid hormones in the pathophysiology and treatment of sarcopenia. Osteoporosis Sarcopenia. 2016;2(3):140–55.PubMedPubMedCentralCrossRef Kim YJ, Tamadon A, Park HT, Kim H, Ku S-Y. The role of sex steroid hormones in the pathophysiology and treatment of sarcopenia. Osteoporosis Sarcopenia. 2016;2(3):140–55.PubMedPubMedCentralCrossRef
7.
go back to reference Spangenburg EE, Geiger PC, Leinwand LA, Lowe DA. Regulation of physiological and metabolic function of muscle by female sex steroids. Med Sci Sports Exerc. 2012;44(9):1653.PubMedPubMedCentralCrossRef Spangenburg EE, Geiger PC, Leinwand LA, Lowe DA. Regulation of physiological and metabolic function of muscle by female sex steroids. Med Sci Sports Exerc. 2012;44(9):1653.PubMedPubMedCentralCrossRef
8.
go back to reference Tay L, Ding YY, Leung BP, Ismail NH, Yeo A, Yew S, et al. Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults. Age (Dordr). 2015;37(6):121.PubMedPubMedCentralCrossRef Tay L, Ding YY, Leung BP, Ismail NH, Yeo A, Yew S, et al. Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults. Age (Dordr). 2015;37(6):121.PubMedPubMedCentralCrossRef
9.
go back to reference Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17(3):327–406.CrossRef Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17(3):327–406.CrossRef
10.
go back to reference Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C. Progression of Mild Cognitive Impairment to Dementia in Clinic- vs Community-Based Cohorts. Arch Neurol. 2009;66(9):1151–7.PubMedPubMedCentralCrossRef Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C. Progression of Mild Cognitive Impairment to Dementia in Clinic- vs Community-Based Cohorts. Arch Neurol. 2009;66(9):1151–7.PubMedPubMedCentralCrossRef
11.
go back to reference Nie H, Xu Y, Liu B, Zhang Y, Lei T, Hui X, et al. The prevalence of mild cognitive impairment about elderly population in China: a meta-analysis. Int J Geriatr Psychiatry. 2011;26(6):558–63.PubMedCrossRef Nie H, Xu Y, Liu B, Zhang Y, Lei T, Hui X, et al. The prevalence of mild cognitive impairment about elderly population in China: a meta-analysis. Int J Geriatr Psychiatry. 2011;26(6):558–63.PubMedCrossRef
12.
go back to reference Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63-75.e2.PubMedCrossRef Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63-75.e2.PubMedCrossRef
14.
go back to reference Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661–71.PubMedCrossRef Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661–71.PubMedCrossRef
15.
go back to reference Petersen RC, Smith GE, Waring SC, Ivnik RJ, Kokmen E, Tangelos EG. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 1997;9(Suppl 1):65–9.PubMedCrossRef Petersen RC, Smith GE, Waring SC, Ivnik RJ, Kokmen E, Tangelos EG. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 1997;9(Suppl 1):65–9.PubMedCrossRef
16.
go back to reference Schmidt R, Kienbacher E, Benke T, Dal-Bianco P, Delazer M, Ladurner G, et al. Sex differences in Alzheimer’s disease. Neuropsychiatr. 2008;22(1):1–15.PubMed Schmidt R, Kienbacher E, Benke T, Dal-Bianco P, Delazer M, Ladurner G, et al. Sex differences in Alzheimer’s disease. Neuropsychiatr. 2008;22(1):1–15.PubMed
18.
19.
go back to reference Gannon OJ, Robison LS, Custozzo AJ, Zuloaga KL. Sex differences in risk factors for vascular contributions to cognitive impairment & dementia. Neurochem Int. 2019;127:38–55.PubMedCrossRef Gannon OJ, Robison LS, Custozzo AJ, Zuloaga KL. Sex differences in risk factors for vascular contributions to cognitive impairment & dementia. Neurochem Int. 2019;127:38–55.PubMedCrossRef
20.
go back to reference Peng T-C, Chen W-L, Wu L-W, Chang Y-W, Kao T-W. Sarcopenia and cognitive impairment: A systematic review and meta-analysis. Clin Nutr. 2020;39(9):2695–701.PubMedCrossRef Peng T-C, Chen W-L, Wu L-W, Chang Y-W, Kao T-W. Sarcopenia and cognitive impairment: A systematic review and meta-analysis. Clin Nutr. 2020;39(9):2695–701.PubMedCrossRef
21.
go back to reference Chang K-V, Hsu T-H, Wu W-T, Huang K-C, Han D-S. Association between sarcopenia and cognitive impairment: a systematic review and meta-analysis. J Am Med Dir Assoc. 2016;17(12):1164 (e7-. e15).CrossRef Chang K-V, Hsu T-H, Wu W-T, Huang K-C, Han D-S. Association between sarcopenia and cognitive impairment: a systematic review and meta-analysis. J Am Med Dir Assoc. 2016;17(12):1164 (e7-. e15).CrossRef
22.
go back to reference Lee AY, Lee J, Oh E, Yoon SJ, Yoon B, Yu SD. Clinical Utility of Seoul Neuropsychological Screening Battery-Core for Dementia Management Project in the Community. J Korean Neurol Assoc. 2019;37(3):277–83.CrossRef Lee AY, Lee J, Oh E, Yoon SJ, Yoon B, Yu SD. Clinical Utility of Seoul Neuropsychological Screening Battery-Core for Dementia Management Project in the Community. J Korean Neurol Assoc. 2019;37(3):277–83.CrossRef
23.
go back to reference Ryu HJ, Yang DW. The Seoul Neuropsychological Screening Battery (SNSB) for Comprehensive Neuropsychological Assessment. Dement Neurocogn Disord. 2023;22(1):1–15.PubMedPubMedCentralCrossRef Ryu HJ, Yang DW. The Seoul Neuropsychological Screening Battery (SNSB) for Comprehensive Neuropsychological Assessment. Dement Neurocogn Disord. 2023;22(1):1–15.PubMedPubMedCentralCrossRef
25.
go back to reference Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology. 1993;43(8):1467–72.PubMedCrossRef Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology. 1993;43(8):1467–72.PubMedCrossRef
26.
go back to reference Jahng S, Na DL, Kang Y. Constructing a Composite Score for the Seoul Neuropsychological Screening Battery-Core. Dement Neurocogn Disord. 2015;14(4):137–42.CrossRef Jahng S, Na DL, Kang Y. Constructing a Composite Score for the Seoul Neuropsychological Screening Battery-Core. Dement Neurocogn Disord. 2015;14(4):137–42.CrossRef
27.
go back to reference Min J-Y, Ha S-W, Lee K, Min K-B. Use of electroencephalogram, gait, and their combined signals for classifying cognitive impairment and normal cognition. Front Aging Neurosci. 2022;14. Min J-Y, Ha S-W, Lee K, Min K-B. Use of electroencephalogram, gait, and their combined signals for classifying cognitive impairment and normal cognition. Front Aging Neurosci. 2022;14.
28.
go back to reference Ida S, Nakai M, Ito S, Ishihara Y, Imataka K, Uchida A, et al. Association Between Sarcopenia and Mild Cognitive Impairment Using the Japanese Version of the SARC-F in Elderly Patients With Diabetes. J Am Med Dir Assoc. 2017;18(9):809.e9-.e13.CrossRef Ida S, Nakai M, Ito S, Ishihara Y, Imataka K, Uchida A, et al. Association Between Sarcopenia and Mild Cognitive Impairment Using the Japanese Version of the SARC-F in Elderly Patients With Diabetes. J Am Med Dir Assoc. 2017;18(9):809.e9-.e13.CrossRef
29.
go back to reference Bouchard DR, Dionne IJ, Brochu M. Sarcopenic/obesity and physical capacity in older men and women: data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study. Obesity (Silver Spring). 2009;17(11):2082–8.PubMedCrossRef Bouchard DR, Dionne IJ, Brochu M. Sarcopenic/obesity and physical capacity in older men and women: data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study. Obesity (Silver Spring). 2009;17(11):2082–8.PubMedCrossRef
30.
go back to reference Weinheimer EM, Sands LP, Campbell WW. A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity. Nutr Rev. 2010;68(7):375–88.PubMedCrossRef Weinheimer EM, Sands LP, Campbell WW. A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity. Nutr Rev. 2010;68(7):375–88.PubMedCrossRef
31.
go back to reference Pasco JA, Williams LJ, Jacka FN, Stupka N, Brennan-Olsen SL, Holloway KL, et al. Sarcopenia and the common mental disorders: a potential regulatory role of skeletal muscle on brain function? Curr Osteoporos Rep. 2015;13:351–7.PubMedCrossRef Pasco JA, Williams LJ, Jacka FN, Stupka N, Brennan-Olsen SL, Holloway KL, et al. Sarcopenia and the common mental disorders: a potential regulatory role of skeletal muscle on brain function? Curr Osteoporos Rep. 2015;13:351–7.PubMedCrossRef
32.
go back to reference Cruz-Jentoft AJ, Landi F, Topinková E, Michel J-P. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13(1):1–7.PubMedCrossRef Cruz-Jentoft AJ, Landi F, Topinková E, Michel J-P. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13(1):1–7.PubMedCrossRef
33.
go back to reference Waite SJ, Maitland S, Thomas A, Yarnall AJ. Sarcopenia and frailty in individuals with dementia: A systematic review. Arch Gerontol Geriatr. 2021;92:104268.PubMedCrossRef Waite SJ, Maitland S, Thomas A, Yarnall AJ. Sarcopenia and frailty in individuals with dementia: A systematic review. Arch Gerontol Geriatr. 2021;92:104268.PubMedCrossRef
34.
go back to reference Nishiguchi S, Yamada M, Shirooka H, Nozaki Y, Fukutani N, Tashiro Y, et al. Sarcopenia as a Risk Factor for Cognitive Deterioration in Community-Dwelling Older Adults: A 1-Year Prospective Study. J Am Med Dir Assoc. 2016;17(4):372.e5-.e8.CrossRef Nishiguchi S, Yamada M, Shirooka H, Nozaki Y, Fukutani N, Tashiro Y, et al. Sarcopenia as a Risk Factor for Cognitive Deterioration in Community-Dwelling Older Adults: A 1-Year Prospective Study. J Am Med Dir Assoc. 2016;17(4):372.e5-.e8.CrossRef
35.
go back to reference Aprahamian I, Cipolli GC, Yassuda MS. Sarcopenia and cognitive impairment: Possible physiopathological causation or just a spurious association? Clin Nutr. 2020;39(5):1622.PubMedCrossRef Aprahamian I, Cipolli GC, Yassuda MS. Sarcopenia and cognitive impairment: Possible physiopathological causation or just a spurious association? Clin Nutr. 2020;39(5):1622.PubMedCrossRef
36.
go back to reference Nagamatsu LS, Chan A, Davis JC, Beattie BL, Graf P, Voss MW, et al. Physical activity improves verbal and spatial memory in older adults with probable mild cognitive impairment: a 6-month randomized controlled trial. J Aging Res. 2013;2013:861893.PubMedPubMedCentralCrossRef Nagamatsu LS, Chan A, Davis JC, Beattie BL, Graf P, Voss MW, et al. Physical activity improves verbal and spatial memory in older adults with probable mild cognitive impairment: a 6-month randomized controlled trial. J Aging Res. 2013;2013:861893.PubMedPubMedCentralCrossRef
37.
go back to reference Erickson KI, Prakash RS, Voss MW, Chaddock L, Hu L, Morris KS, et al. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus. 2009;19(10):1030–9.PubMedPubMedCentralCrossRef Erickson KI, Prakash RS, Voss MW, Chaddock L, Hu L, Morris KS, et al. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus. 2009;19(10):1030–9.PubMedPubMedCentralCrossRef
38.
go back to reference Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ, Acha AA, Ostir GV. Androgen treatment and muscle strength in elderly men: A meta-analysis. J Am Geriatr Soc. 2006;54(11):1666–73.PubMedPubMedCentralCrossRef Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ, Acha AA, Ostir GV. Androgen treatment and muscle strength in elderly men: A meta-analysis. J Am Geriatr Soc. 2006;54(11):1666–73.PubMedPubMedCentralCrossRef
39.
go back to reference Yagi S, Galea LAM. Sex differences in hippocampal cognition and neurogenesis. Neuropsychopharmacology. 2019;44(1):200–13.PubMedCrossRef Yagi S, Galea LAM. Sex differences in hippocampal cognition and neurogenesis. Neuropsychopharmacology. 2019;44(1):200–13.PubMedCrossRef
40.
go back to reference Geraci A, Calvani R, Ferri E, Marzetti E, Arosio B, Cesari M. Sarcopenia and Menopause: The Role of Estradiol. Front Endocrinol (Lausanne). 2021;12:682012.PubMedCrossRef Geraci A, Calvani R, Ferri E, Marzetti E, Arosio B, Cesari M. Sarcopenia and Menopause: The Role of Estradiol. Front Endocrinol (Lausanne). 2021;12:682012.PubMedCrossRef
41.
go back to reference Epperson CN, Sammel MD, Freeman EW. Menopause effects on verbal memory: findings from a longitudinal community cohort. J Clin Endocrinol Metab. 2013;98(9):3829–38.PubMedPubMedCentralCrossRef Epperson CN, Sammel MD, Freeman EW. Menopause effects on verbal memory: findings from a longitudinal community cohort. J Clin Endocrinol Metab. 2013;98(9):3829–38.PubMedPubMedCentralCrossRef
42.
go back to reference Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 1992;17(5):485–95.PubMedCrossRef Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 1992;17(5):485–95.PubMedCrossRef
43.
go back to reference Messier V, Rabasa-Lhoret R, Barbat-Artigas S, Elisha B, Karelis AD, Aubertin-Leheudre M. Menopause and sarcopenia: A potential role for sex hormones. Maturitas. 2011;68(4):331–6.PubMedCrossRef Messier V, Rabasa-Lhoret R, Barbat-Artigas S, Elisha B, Karelis AD, Aubertin-Leheudre M. Menopause and sarcopenia: A potential role for sex hormones. Maturitas. 2011;68(4):331–6.PubMedCrossRef
44.
go back to reference Bedard K, Deschênes O. The Long-Term Impact of Military Service on Health: Evidence from World War II and Korean War Veterans. Am Econ Rev. 2006;96(1):176–94.PubMedCrossRef Bedard K, Deschênes O. The Long-Term Impact of Military Service on Health: Evidence from World War II and Korean War Veterans. Am Econ Rev. 2006;96(1):176–94.PubMedCrossRef
45.
go back to reference Ikin JF, Sim MR, McKenzie DP, Horsley KWA, Wilson EJ, Harrex WK, et al. Life satisfaction and quality in Korean War veterans five decades after the war. J Epidemiol Community Health. 2009;63(5):359–65.PubMedCrossRef Ikin JF, Sim MR, McKenzie DP, Horsley KWA, Wilson EJ, Harrex WK, et al. Life satisfaction and quality in Korean War veterans five decades after the war. J Epidemiol Community Health. 2009;63(5):359–65.PubMedCrossRef
Metadata
Title
Sex differences in the association between sarcopenia and mild cognitive impairment in the older Korean population
Authors
Hyo-jung Lee
Ju-Young Choi
Dongui Hong
Donghoon Kim
Jin-Young Min
Kyoung-Bok Min
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-03911-4

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine